Quality of Life in Hypoparathyroidism Improves With rhPTH(1-84) Throughout 8 Years of Therapy

CONTEXT: Calcium and vitamin D treatment does not improve reduced quality of life (QOL) in hypoparathyroidism. Recombinant human (rh) PTH(1-84) therapy improves QOL metrics for up to 5 years. Data on QOL beyond this time point are not available. OBJECTIVES: To evaluate the effects of 8 years of rhPT...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Endocrinol Metab
Main Authors: Tabacco, Gaia, Tay, Yu-Kwang Donovan, Cusano, Natalie E, Williams, John, Omeragic, Beatriz, Majeed, Rukhana, Almonte, Maximo Gomez, Rubin, Mishaela R, Bilezikian, John P
Format: Artigo
Language:Inglês
Published: Endocrine Society 2019
Subjects:
Clinical Research Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6530656/
https://ncbi.nlm.nih.gov/pubmed/30776291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2018-02430
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items